Optas, LLC Gilead Sciences, Inc. Transaction History

Optas, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 27, 2021	SELL	$56.65 - $64.55 $196,462 - $223,859	-3,468 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$62.1 - $78.08 $215,362 - $270,781	3,468 New	3,468 $220,000
Q2 2020 Jul 31, 2020	SELL	$72.34 - $84.0 $283,138 - $328,776	-3,914 Closed	0 $0
Q1 2020 Apr 14, 2020	SELL	$62.63 - $80.22 $625,548 - $801,237	-9,988 Reduced 71.85%	3,914 $294,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $856,641 - $942,277	13,902 New	13,902 $903,000

1,923

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

Stay updated on Optas, LLC with notifications on news.